Lifevantage Corp (LFVN) stock
LFVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 16/3023% below fair value
$4.97−0.07 (-1.39%)
Close on Nov 13, 2026Market cap $62.26MP/E 23.7Yield 3.72%
Lifevantage profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Lifevantage's profit margin for the twelve months ending Sep 30, 2026 was 1.6%. For fiscal 2026 it was 2.8%, against 4.3% the year before. The highest annual figure on record is 9.9% in fiscal 2012.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | 2.8% | −1.5 |
| FY2025 | Jun 30, 2025 | 4.3% | +2.8 |
| FY2024 | Jun 30, 2024 | 1.5% | +0.3 |
| FY2023 | Jun 30, 2023 | 1.2% | −0.3 |
| FY2022 | Jun 30, 2022 | 1.5% | −4.3 |
| FY2021 | Jun 30, 2021 | 5.9% | +0.9 |
| FY2020 | Jun 30, 2020 | 5.0% | +1.7 |
| FY2019 | Jun 30, 2019 | 3.3% | +0.5 |
| FY2018 | Jun 30, 2018 | 2.8% | +2.0 |
| FY2017 | Jun 30, 2017 | 0.8% | −2.2 |
| FY2016 | Jun 30, 2016 | 3.0% | −0.8 |
| FY2015 | Jun 30, 2015 | 3.7% | −1.6 |
| FY2014 | Jun 30, 2014 | 5.3% | +1.7 |
| FY2013 | Jun 30, 2013 | 3.7% | −6.2 |
| FY2012 | Jun 30, 2012 | 9.9% | +140.4 |
| FY2011 | Jun 30, 2011 | -130.5% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | -0.5% | −5.1 |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | 3.0% | −0.5 |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | 3.1% | −2.8 |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | 0.6% | −3.2 |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | 4.5% | +0.7 |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | 3.6% | +0.9 |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | 5.9% | +2.5 |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | 3.8% | +5.0 |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | 3.9% | +2.6 |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | 2.7% | −1.0 |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | 3.4% | +1.5 |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | -1.3% | +0.7 |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | 1.2% | +0.0 |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | 3.6% | +6.4 |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | 1.9% | −0.4 |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | -2.0% | −2.1 |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | 1.2% | −5.1 |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | -2.8% | −11.7 |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | 2.3% | −1.1 |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | 0.2% | −6.3 |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | 6.2% | +1.8 |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | 9.0% | +2.5 |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | 3.3% | +0.4 |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | 6.5% | −0.6 |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | 4.5% | +1.3 |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | 6.4% | −0.5 |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | 3.0% | −0.2 |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | 7.0% | +5.6 |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | 3.1% | +1.5 |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | 7.0% | +1.4 |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | 3.2% | −0.1 |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | 1.4% | +0.8 |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | 1.6% | −0.0 |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | 5.5% | +5.4 |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | 3.2% | +3.1 |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | 0.6% | +0.1 |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | 1.7% | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | 0.2% | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | 0.1% | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | 0.6% | – |
See a number that looks wrong?